- Depression
- Planning for student-led presentations
2018-11-08 16:27:54
Left Hippocampus
Right Hippocampus
[a] patients v. ctrls, [b] patients on SSRIs, [c] patients v. ctrls (happy stim), [d] patients v. controls (sad stim)
"…we performed the first meta-analysis of the mood effects in ATD and APTD studies. The depletion of monoamine systems (both 5-HT and NE/DA) does not decrease mood in healthy controls. However, in healthy controls with a family history of MDD the results suggest that mood is slightly decreased…by [monoamine depletion]…"
Audhya, T., Adams, J. B., & Johansen, L. (2012). Correlation of serotonin levels in CSF, platelets, plasma, and urine. Biochimica et Biophysica Acta, 1820(10), 1496–1501. https://doi.org/10.1016/j.bbagen.2012.05.012
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry, 47(4), 351–354. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10686270
Burke, H. M., Davis, M. C., Otte, C., & Mohr, D. C. (2005). Depression and cortisol responses to psychological stress: A meta-analysis. Psychoneuroendocrinology, 30(9), 846–856. https://doi.org/10.1016/j.psyneuen.2005.02.010
Cheng, W., Rolls, E. T., Qiu, J., Liu, W., Tang, Y., Huang, C.-C., … Feng, J. (2016). Medial reward and lateral non-reward orbitofrontal cortex circuits change in opposite directions in depression. Brain, aww255. https://doi.org/10.1093/brain/aww255
Dierckx, B., Heijnen, W. T., Broek, W. W. van den, & Birkenhäger, T. K. (2012). Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: A meta-analysis. Bipolar Disorders, 14(2), 146–150. https://doi.org/10.1111/j.1399-5618.2012.00997.x
Duman, R. S., & Aghajanian, G. K. (2012). Synaptic dysfunction in depression: Potential therapeutic targets. Science, 338(6103), 68–72. https://doi.org/10.1126/science.1222939
Duman, R. S., & Voleti, B. (2012). Signaling pathways underlying the pathophysiology and treatment of depression: Novel mechanisms for rapid-acting agents. Trends Neurosci., 35(1), 47–56. https://doi.org/10.1016/j.tins.2011.11.004
Fitzgerald, P. B., Laird, A. R., Maller, J., & Daskalakis, Z. J. (2008). A meta-analytic study of changes in brain activation in depression. Human Brain Mapping, 29(6), 683–695. https://doi.org/10.1002/hbm.20426
Frohlich, J., & Van Horn, J. D. (2014). Reviewing the ketamine model for schizophrenia. J. Psychopharmacol., 28(4), 287–302. https://doi.org/10.1177/0269881113512909
Goldstein-Piekarski, A. N., Korgaonkar, M. S., Green, E., Suppes, T., Schatzberg, A. F., Hastie, T., … Williams, L. M. (2016). Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants. Proceedings of the National Academy of Sciences, 113(42), 11955–11960. https://doi.org/10.1073/pnas.1606671113
Hamilton, J. P., Etkin, A., Furman, D. J., Lemus, M. G., Johnson, R. F., & Gotlib, I. H. (2012). Functional neuroimaging of major depressive disorder: A Meta-Analysis and new integration of baseline activation and neural response data. AJP, 169(7), 693–703. https://doi.org/10.1176/appi.ajp.2012.11071105
Leung, J., Selvage, C., Bosdet, T., Branov, J., Rosen-Heath, A., Bishop, C., … Horvath, G. (2018). Salivary serotonin does not correlate with central serotonin turnover in adult phenylketonuria (PKU) patients. Molecular Genetics and Metabolism Reports, 15, 100–105. https://doi.org/10.1016/j.ymgmr.2018.03.008
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., … Duman, R. S. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science, 329(5994), 959–964. https://doi.org/10.1126/science.1190287
Mahar, I., Bambico, F. R., Mechawar, N., & Nobrega, J. N. (2014). Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neuroscience & Biobehavioral Reviews, 38, 173–192. https://doi.org/10.1016/j.neubiorev.2013.11.009
Medici, M., Direk, N., Visser, W. E., Korevaar, T. I. M., Hofman, A., Visser, T. J., … Peeters, R. P. (2014). Thyroid function within the normal range and the risk of depression: A population-based cohort study. J. Clin. Endocrinol. Metab., 99(4), 1213–1219. https://doi.org/10.1210/jc.2013-3589
Palazidou, E. (2012). The neurobiology of depression. British Medical Bulletin, 101, 127–145. https://doi.org/10.1093/bmb/lds004
Ruhé, H. G., Mason, N. S., & Schene, A. H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. Molecular Psychiatry, 12(4), 331–359. https://doi.org/10.1038/sj.mp.4001949
Samuelsson, M., Jokinen, J., Nordström, A.-L., & Nordström, P. (2006). CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Acta Psychiatrica Scandinavica, 113(1), 44–47. https://doi.org/10.1111/j.1600-0447.2005.00639.x
Sheline, Y. I., Price, J. L., Yan, Z., & Mintun, M. A. (2010). Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc. Natl. Acad. Sci. U. S. A., 107(24), 11020–11025. https://doi.org/10.1073/pnas.1000446107
Tiger, M., Svenningsson, P., Nord, M., Jabre, S., Halldin, C., & Lundberg, J. (2015). No correlation between serotonin and its metabolite 5-HIAA in the cerebrospinal fluid and [11C]AZ10419369 binding measured with PET in healthy volunteers. Retrieved from http://hdl.handle.net/10616/44513
Videbech, P., & Ravnkilde, B. (2004a). Hippocampal volume and depression: A meta-analysis of MRI studies. Am. J. Psychiatry, 161(11), 1957–1966. https://doi.org/10.1176/appi.ajp.161.11.1957
Videbech, P., & Ravnkilde, B. (2004b). Hippocampal volume and depression: A meta-analysis of mri studies. American Journal of Psychiatry, 161(11), 1957–1966. https://doi.org/10.1176/appi.ajp.161.11.1957
Zarate, C. A., Jr, Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., … Manji, H. K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry, 63(8), 856–864. https://doi.org/10.1001/archpsyc.63.8.856